Skip to Content

MYLAN 7155 MYLAN 7155 (Budesonide (Enteric Coated) 3 mg)

Pill with imprint MYLAN 7155 MYLAN 7155 is Red, Capsule-shape and has been identified as Budesonide (Enteric Coated) 3 mg. It is supplied by Mylan Pharmaceuticals Inc..

Budesonide is used in the treatment of crohn's disease; asthma, maintenance; crohn's disease, acute; crohn's disease, maintenance; ulcerative colitis, active and belongs to the drug classes glucocorticoids, inhaled corticosteroids. Risk cannot be ruled out during pregnancy. Budesonide 3 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for MYLAN 7155 MYLAN 7155

Budesonide (enteric coated) 3 mg MYLAN 7155 MYLAN 7155
Budesonide (enteric coated) 3 mg MYLAN 7155 MYLAN 7155
Budesonide (enteric coated) 3 mg MYLAN 7155 MYLAN 7155

Budesonide (Enteric Coated)

MYLAN 7155 MYLAN 7155
3 mg
18.00 mm
Prescription only
Drug Class
Glucocorticoids, Inhaled corticosteroids
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Mylan Pharmaceuticals Inc.
Inactive Ingredients
acetyltributyl citrate, silicon dioxide, dimethicone, ethylcelluloses, FD&C Red No. 40, gelatin, lactose monohydrate, magnesium stearate, methacrylic acid - ethyl acrylate copolymer (1:1) type a, polysorbate 80, sodium hydroxide, sodium lauryl sulfate, magnesium silicate, titanium dioxide, triethyl citrate, ferrosoferric oxide, D&C Yellow No. 10, FD&C Blue No. 1, FD&C Blue No. 2, propylene glycol, shellac

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
00378-7155 Mylan Pharmaceuticals Inc.
51079-0020 UDL Laboratories Inc.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.